This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bordeaux, J.
Right arrow Articles by Moroianu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bordeaux, J.
Right arrow Articles by Moroianu, J.

 Previous Article  |  Next Article 

Journal of Virology, August 2006, p. 8259-8262, Vol. 80, No. 16
0022-538X/06/$08.00+0     doi:10.1128/JVI.00776-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

The L2 Minor Capsid Protein of Low-Risk Human Papillomavirus Type 11 Interacts with Host Nuclear Import Receptors and Viral DNA

J. Bordeaux, S. Forte, E. Harding, M. S. Darshan, K. Klucevsek, and J. Moroianu*

Biology Department, Boston College, Chestnut Hill, Massachusetts 02467

Received 17 April 2006/ Accepted 30 May 2006


arrow
ABSTRACT
 
Analysis of the interactions of low-risk human papillomavirus type 11 (HPV11) L2 with karyopherin ß (Kap ß) nuclear import receptors revealed that L2 interacted with Kap ß1, Kap ß2, and Kap ß3 and formed a complex with the Kap {alpha}2ß1 heterodimer. HPV11 L2 contains two nuclear localization signals (NLSs)—in the N terminus and the C terminus—that could mediate its nuclear import via a classical pathway. Each NLS was functional in vivo, and deletion of both of them abolished L2 nuclear localization. Both NLSs interacted with the viral DNA. Thus, HPV11 L2 can interact with several karyopherins and the viral DNA and may enter the nucleus via multiple pathways.


arrow
TEXT
 
Human papillomavirus (HPV) virions consist of a single molecule of 8-kb double-stranded circular DNA contained within a spherical capsid composed of 72 L1 capsomers and the L2 minor capsid protein, estimated to have 36 molecules per capsid (10, 15). Although L1 expressed alone in mammalian cells harboring episomal DNA forms virions (18), L2 expression is required for efficient encapsidation of the viral DNA (15, 17). Expression and nuclear import of L2 during the productive stage precede the expression and nuclear translocation of L1 (5). Studies with HPV virions in raft cultures have shown that L2 participates in at least two steps in the production of infectious virus (7). L2 binds to cells (9, 19) and interacts with ß-actin and tSNARE syntaxin 18 (1, 20) and also facilitates the escape of the viral genome from the endocytic compartment after viral uncoating (8). Cleavage of L2 at a furin consensus site located in the N terminus was reported to be required for infection (14). Bovine papillomavirus type 1 (BPV1) L2 termini required for infectivity can function as nuclear localization signals (NLSs) mediating nuclear import via a classical pathway, and the C-terminal NLS (cNLS) can also interact with the viral DNA (4). These results, together with the colocalization of the incoming L2 and genome in the nucleus at ND10 (3), suggest that BPV1 L2 may facilitate the nuclear localization of the genome in the initial stages of infection. In a related virus, simian virus 40, nuclear import of simian virus 40 DNA is mediated by the VP3 capsid protein via interaction with the importin heterodimer (12).

Active nuclear import of proteins is mediated by import receptors of the karyopherin ß (Kap ß)/importin ß superfamily that interact with nucleoporins at the nuclear pore complex to transport the proteins into the nucleus. Binding of nuclear RanGTP to the Kap ßs causes dissociation of the import complexes, leading to the release of the transported cargoes inside the nucleus (6, 11). In this study we investigated the interactions of the L2 minor capsid protein of low-risk HPV11 with import receptors and viral DNA and mapped its NLSs and DNA binding sites.

The His-tagged HPV11 L2 contained in the pProEX HTb plasmid vector (16) was expressed in Escherichia coli BL21-CodonPlus and purified as previously described (2). We analyzed the interactions between His-tagged HPV11 L2 and the karyopherins via overlay blotting assays (2). The L2 blots were either detected with an anti-His antibody or incubated with increasing concentrations of different Kaps (Fig. 1). The Kap {alpha}2 adapter bound to L2 at concentrations of 2.5 and 5 µg/ml Kap {alpha}2 in either the absence or presence of Kap ß1 (Fig. 1A, lanes 3, 4, 6, and 7). Glutathione S-transferase (GST)-Kap ß1 bound directly to L2, but in the presence of increasing concentrations of Kap {alpha}2, the amount of Kap ß1 bound increased (Fig. 1A, lanes 8, 10, and 11). Moreover, RanGTP inhibited the formation of the Kap {alpha}2ß1/L2 complex (Fig. 1A, lane 12), suggesting that the complex can be dissociated in the nucleus by RanGTP. GST did not bind L2 (Fig. 1A, lane 13). These data suggest that HPV11 L2 forms an import complex with Kap {alpha}2ß1 heterodimers via interaction with the Kap {alpha}2adapter.


Figure 1
View larger version (24K):
[in this window]
[in a new window]
 
FIG. 1. HPV11 L2 forms a complex with the Kap {alpha}2ß1 heterodimer and interacts with the Kap ß1, Kap ß2, and Kap ß3 import receptors. Purified HPV11 L2 was subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto a nitrocellulose membrane. (A) One L2 blot was detected with anti-His antibody (lane 1). Other L2 blots were incubated with increasing concentrations of Kap {alpha}2 in the absence (lanes 2 to 4) or in the presence (lanes 5 to 7 and 9 to 11) of 5 µg/ml GST-Kap ß1. For lane 12, the L2 blot was incubated with Kap {alpha}2 and GST-Kap ß1 plus RanGTP. Separate L2 blots were incubated with GST-Kap ß1 alone (lane 8) or GST (lane 13). Bound Kap {alpha}2 was detected with an anti-Kap {alpha}2 antibody (Ab) (lanes 2 to 7), and bound GST-Kap ß1 and GST were detected with an anti-GST Ab (lanes 8 to 13). (B) L2 blots were incubated with either anti-His Ab (lane 1) or with 5 µg/ml GST and then anti-GST Ab (lane 2). (C) L2 blots were incubated with increasing concentrations of GST-Kap ß1 (lanes 1 to 4) or with GST-Kap ß1 plus RanGTP (lane 5), and the bound GST-Kap ß1 was detected with an anti-GST Ab. For panels D and E, similar incubations were done with GST-Kap ß2 and GST-Kap ß3, respectively.

Three import receptors interacted directly with HPV11 L2 but with different affinities: GST-Kap ß1 at concentrations of 10 and 15 µg/ml (Fig. 1C), GST-Kap ß2 at 5 and 10 µg/ml (Fig. 1D), and GST-Kap ß3 at 2 and 5 µg/ml (Fig. 1E). GST did not interact with HPV11 L2 (Fig. 1B). Significantly, RanGTP inhibited the interactions between each Kap ß import receptor and L2 (Fig. 1C, D, and E, lanes 5). We have previously shown that high-risk HPV16 L2 interacts with Kap {alpha}2ß1, Kap ß2, and Kap ß3 (2). Thus, L2 of low-risk HPV11 has a conserved pattern of interactions with HPV16 L2 but also interacts directly with Kap ß1. In contrast, BPV1 L2 interacts with Kap {alpha}2ß1 heterodimers but not with either Kap ß2 or Kap ß3 (4).

HPV16 L2 contains two NLSs, localized near the N terminus (nNLS) and the C terminus, that can independently mediate nuclear import of L2 (2), and in other HPV L2 proteins, these positively charged sequences are partially conserved. We made GST fusion proteins as previously described (2) with the corresponding N-terminal sequence (nNLS = 1MKPRARRRKRA11) and C-terminal sequence (cNLS = 439ARRRRKRI446) of HPV11 L2 and analyzed them in nuclear import assays in digitonin-permeabilized HeLa cells (2). This analysis revealed that both the nNLS and the cNLS could mediate nuclear import of a GST reporter in the presence of either exogenous cytosol containing the karyopherins or recombinant Kap {alpha}2ß1 heterodimers plus RanGDP (Fig. 2, panels B, C, E, and F). GST-NLS16L1, used as positive control for the classical pathway (13), was also imported in the presence of either cytosol or Kap {alpha}2ß1 plus RanGDP (Fig. 2, panels H and I), whereas GST was not (Fig. 2, panels K and L). In agreement with these data, in solution binding assays performed as previously described (2) both the nNLS and cNLS formed complexes with Kap {alpha}2ß1 heterodimers via interaction with Kap {alpha}2, with the nNLS having a higher affinity than the cNLS (data not shown). Assays of L2 or the L2 mutants binding to Kap ß2/3 receptors revealed that deletion of the nNLS abolishes the interaction of HPV11 L2 with Kap ß2/3 (data not shown), suggesting that the nNLS is required for these interactions, as it is for HPV16 L2 (2).


Figure 2
View larger version (49K):
[in this window]
[in a new window]
 
FIG. 2. Both the nNLS and the cNLS of HPV11 L2 can mediate nuclear import via a classical pathway. Digitonin-permeabilized HeLa cells were incubated with 0.25 µg of either GST-nNLS11L2 (panels A to C), GST-cNLS11L2 (panels D to F), GST-NLS16L1 (panels G to I), or GST (panels J to L) in the presence of either transport buffer only (panels A, D, G, and J), HeLa cytosol (panels B, E, H, and K), or Kap {alpha}2ß1 heterodimers (1 µg each) plus RanGDP (3 µg) (panels C, F, I, and L). Note the nuclear import in panels B, C, E, F, H, and I.

To examine the roles of the nNLS and cNLS of HPV11 L2 in vivo, we generated plasmids containing enhanced green fluorescent protein-L2 (EGFP-L2), EGFP-L2{Delta}N (lacking the nNLS), EGFP-L2{Delta}C (lacking the cNLS), and EGFP-L2{Delta}N{Delta}C (lacking both NLSs), using the pEGFP-C1 plasmid (Clontech, Inc.), carried out transfection assays in HeLa cells, and examined the localization of EGFP-L2 fusion proteins via fluorescence microscopy. EGFP-L2 showed a clear nuclear localization, in contrast with the diffuse localization of the EGFP throughout the cell (Fig. 3A, panels A and C). Although the EGFP is small enough to passively diffuse through the nuclear pore complex, EGFP-L2 (as well as L2 itself) is above the limit of passive diffusion and its nuclear localization requires an NLS(s). Both EGFP-L2{Delta}N and EGFP-L2{Delta}C had a predominant nuclear localization in HeLa cells (Fig. 3B, panels A and C), suggesting that either NLS can mediate nuclear import of L2 in vivo. In contrast, localization of EGFP-L2{Delta}N{Delta}C lacking both NLSs was mostly cytoplasmic (Fig. 3B, panel E), suggesting the absence of an additional NLS in HPV11 L2.


Figure 3
View larger version (40K):
[in this window]
[in a new window]
 
FIG. 3. The nNLS and cNLS of HPV11 L2 can independently mediate nuclear localization of L2 in vivo. HeLa cells were transfected with either EGFP-L2 (A, panels A and B), EGFP (A, panels C and D), EGFP-L2{Delta}N (B, panels A and B), EGFP-L2{Delta}C (B, panels C and D), or EGFP-L2{Delta}N{Delta}C (B, panels E and F) plasmids, using FUGENE 6, and were examined by fluorescence microscopy at 24 h posttransfection. The fluorescence of the EGFP is shown in the left column and DAPI (4',6'-diamidino-2-phenylindole) staining of the nuclei is shown in the right column.

We previously showed that BPV1 L2 interacts via its cNLS with DNA in a DNA sequence-independent manner (4). We analyzed the interactions of the two NLSs of HPV11 L2 and HPV16 L2 with either the HPV16 DNA plasmid or an unrelated DNA using DNA mobility shift assays (4). Each NLS interacted efficiently with the viral DNA and with the unrelated DNA, whereas GST did not (Fig. 4) (data not shown). Deletion of both NLSs in the L2{Delta}N{Delta}C strongly inhibited the interaction of the L2 proteins with the DNA (data not shown). These data suggest that the NLSs of HPV11 and HPV16 L2 proteins are their DNA binding sites and that this DNA binding occurs without nucleotide sequence specificity.


Figure 4
View larger version (16K):
[in this window]
[in a new window]
 
FIG. 4. Both the nNLSs and cNLSs of high-risk HPV16 L2 and low-risk HPV11 L2 interact with DNA. An HPV16 DNA plasmid (lane 1) was incubated with increasing amounts (2, 5, or 10 µg of protein) of either GST-nNLS16L2 (lanes 2 to 4), GST-nNLS11L2 (lanes 5 to 7), GST-cNLS16L2 (lanes 8 to 10), or GST-cNLS11L2 (lanes 11 to 13) or 10 µg of GST (lane 14) and analyzed via agarose gel electrophoresis.

Overall, the data show that HPV11 L2 interacts via its two NLSs with several Kaps and the viral DNA and may enter the nucleus via multiple pathways. The high-affinity binding of HPV11 L2 to Kap ß2 and Kap ß3 suggests that the pathways mediated by these import receptors may be preferentially used by L2 in conditions of competition with host proteins for the classical pathway. Future studies in vivo with HPV L2 proteins and specific mutants will investigate how interference with NLS function affects HPV infection and analyze the potential role of L2 proteins in the nuclear localization of the viral DNA.


arrow
ACKNOWLEDGMENTS
 
We thank G. Blobel, Y. M. Chook, S. Adam, G. Dreyfuss, K. Weis, A. Lamond, N. Yaseen, and R. Roden for their generous gifts of expression vectors. We thank Kaitlin Quinn and Anna Leszczynski for technical assistance in preparation of recombinant transport factors and L2 proteins.

This work was supported by a grant from the National Institutes of Health (1-RO1 CA94898-01) to J.M.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Boston College, Biology Department, Higgins Hall, Room 578, 140 Commonwealth Avenue, Chestnut Hill, MA 02467. Phone: (617) 552-1713. Fax: (617) 552-2011. E-mail: moroianu{at}bc.edu. Back


arrow
REFERENCES
 
    1
  1. Bossis, I., R. B. Roden, R. Gambhira, R. Yang, M. Tagaya, P. M. Howley, and P. I. Meneses. 2005. Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection. J. Virol. 79:6723-6731.[Abstract/Free Full Text]
  2. 2
  3. Darshan, M. S., J. Lucchi, E. Harding, and J. Moroianu. 2004. The L2 minor capsid protein of human papillomavirus type 16 interacts with a network of nuclear import receptors. J. Virol. 78:12179-12188.[Abstract/Free Full Text]
  4. 3
  5. Day, P. M., C. C. Baker, D. R. Lowy, and J. T. Schiller. 2004. Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc. Natl. Acad. Sci. USA 101:14252-14257.[Abstract/Free Full Text]
  6. 4
  7. Fay, A., W. H. Yutzy IV, R. B. S. Roden, and J. Moroianu. 2004. The positively charged termini of L2 minor capsid protein required for bovine papillomavirus infection function separately in nuclear import and DNA binding. J. Virol. 78:13447-13454.[Abstract/Free Full Text]
  8. 5
  9. Florin, L., C. Sapp, R. E. Streeck, and M. Sapp. 2002. Assembly and translocation of papillomavirus capsid proteins. J. Virol. 76:10009-10014.[Abstract/Free Full Text]
  10. 6
  11. Fried, H., and U. Kutay. 2003. Nucleocytoplasmic transport: taking an inventory. Cell. Mol. Life Sci. 60:1659-1688.[CrossRef][Medline]
  12. 7
  13. Holmgren, S. C., N. A. Patterson, M. A. Ozbun, and P. F. Lambert. 2005. The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J. Virol. 79:3938-3948.[Abstract/Free Full Text]
  14. 8
  15. Kamper, N., P. M. Day, T. Nowak, H. C. Selinka, L. Florin, J. Bolscher, L. Hilbig, J. T. Schiller, and M. Sapp. 2006. A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J. Virol. 80:759-768.[Abstract/Free Full Text]
  16. 9
  17. Kawana, K., K. Matsumoto, H. Yoshikawa, Y. Taketani, T. Kawana, K. Yoshiike, and T. Kanda. 1998. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2. Virology 245:353-359.[CrossRef][Medline]
  18. 10
  19. Kirnbauer, R., J. Taub, H. Greenstone, R. Roden, M. Durst, L. Gissmann, D. R. Lowy, and J. T. Schiller. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.[Abstract/Free Full Text]
  20. 11
  21. Moroianu, J. 1999. Nuclear import and export pathways. J. Cell Biochem. Suppl. 32-33:76-83.[CrossRef]
  22. 12
  23. Nakanishi, A., D. Shum, H. Morioka, E. Otsuka, and H. Kasamatsu. 2002. Interaction of the Vp3 nuclear localization signal with the importin {alpha}2/ ß heterodimer directs nuclear entry of infecting simian virus 40. J. Virol. 76:9368-9377.[Abstract/Free Full Text]
  24. 13
  25. Nelson, L. M., R. C. Rose, and J. Moroianu. 2002. Nuclear import strategies of high risk HPV16 L1 major capsid protein. J. Biol. Chem. 277:23958-23964.[Abstract/Free Full Text]
  26. 14
  27. Richards, R. M., D. R. Lowy, J. T. Schiller, and P. M. Day. 2006. Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc. Natl. Acad. Sci. USA 103:1522-1527.[Abstract/Free Full Text]
  28. 15
  29. Roden, R. B., H. L. Greenstone, R. Kirnbauer, F. P. Booy, J. Jessie, D. R. Lowy, and J. T. Schiller. 1996. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 70:5875-5883.[Abstract]
  30. 16
  31. Roden, R. B., R. Kirnbauer, A. B. Jenson, D. R. Lowy, and J. T. Schiller. 1994. Interaction of papillomaviruses with the cell surface. J. Virol. 68:7260-7266.[Abstract/Free Full Text]
  32. 17
  33. Stauffer, Y., K. Raj, K. Masternak, and P. Beard. 1998. Infectious human papillomavirus type 18 pseudovirions. J. Mol. Biol. 283:529-536.[CrossRef][Medline]
  34. 18
  35. Unckell, F., R. E. Streeck, and M. Sapp. 1997. Generation and neutralization of pseudovirions of human papillomavirus type 33. J. Virol. 71:2934-2939.[Abstract]
  36. 19
  37. Yang, R., P. M. Day, W. H. Yutzy IV, K.-Y. Lin, C.-F. Hung, and R. B. S. Roden. 2003. Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J. Virol. 77:3531-3541.[Abstract/Free Full Text]
  38. 20
  39. Yang, R., W. H. Yutzy IV, R. P. Viscidi, and R. B. Roden. 2003. Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection. J. Biol. Chem. 278:12546-12553.[Abstract/Free Full Text]


Journal of Virology, August 2006, p. 8259-8262, Vol. 80, No. 16
0022-538X/06/$08.00+0     doi:10.1128/JVI.00776-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Conway, M.J., Meyers, C. (2009). Replication and Assembly of Human Papillomaviruses. JDR 88: 307-317 [Abstract] [Full Text]  
  • Laniosz, V., Nguyen, K. C., Meneses, P. I. (2007). Bovine Papillomavirus Type 1 Infection Is Mediated by SNARE Syntaxin 18. J. Virol. 81: 7435-7448 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bordeaux, J.
Right arrow Articles by Moroianu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bordeaux, J.
Right arrow Articles by Moroianu, J.